Mr. Furqan Kabir, M.Phil, MSc, MBA - Aga Khan University, Hospital - Manager, Outreach & Research Lab

Mr. Furqan Kabir

M.Phil, MSc, MBA

Aga Khan University, Hospital

Manager, Outreach & Research Lab

Karachi, Sindh | Pakistan

Main Specialties: Biotechnology

Additional Specialties: Molecular Epidemiology of Infectious diseases


Top Author

Mr. Furqan Kabir, M.Phil, MSc, MBA - Aga Khan University, Hospital - Manager, Outreach & Research Lab

Mr. Furqan Kabir

M.Phil, MSc, MBA

Introduction

FURQAN KABIR
House# R-424 sector 11-C-3 Sirsyed town North Karachi, 75850, Karachi, Pakistan
Phone: +92(322)3689845; Skype ID: furqan.kabir
E-mail: furqan.kabir@yahoo.com; furqan.kabir@gmail.com; Linkedin: https://pk.linkedin.com/in/furqan-kabir-ab8280a;
Academia.edu: http://aku.academia.edu/FurqanKabir; ResearchGate: https://www.researchgate.net/profile/Furqan_Kabir;

________________________________________________PROFILE SUMMARY____________________________________________
Qualification: MPhil. (Biosciences, SZABIST, PK), MSc (Biotechnology, UOK, PK), MBA (Health & Hospital Management,
IOBM/CBM, PK)
Fellowships/Courses: Completed an yearlong Biosafety & Biosecurity program i.e. ASM 52 weeks of Biosafety, sponsored by ASM
& mentored by Sean Kauffman. Completed 04 modules (Biorisk Mgmt. Use & Care of BSCs, Dual use
Research of concern, Waste Mgmt.), offered by Frontline Foundation.
Certification: Intl. federation of Biosafety Associations (IFBA) certified professional for Biorisk Management & Biosafety
Cabinet Selection, Installation & Safe Use, Certified Laboratory Biosafety Professional from Intl.
Biocontainment training Centre, utmb, US.
Experience: 13 Years of Laboratory (BSL-2,3) experience in Molecular biology at Aga Khan University, Hospital, serving as
Safety Coordinator for Dept. of Paediatrics & Child Health, Aga Khan University since 2009.
Current Designation: Manager, Infectious Diseases Research Laboratory (IDRL) & outreach, Quality & Safety Coordinator at Dept.
of Paediatrics & Child Health, Aga Khan University, Hospital.
International Affiliations: Member of Safety & Security Committee at iGEM Foundation (The International Genetically Engineered
Machine Competition, US), iGEM Safety and Security Committee is a group of experts in biosafety,
biosecurity, and risk assessment. Its members come from diverse areas of industry, academia, and
government. The committee helps create iGEM's safety and security program and gives expert advice on
potential safety and security issues in the competition. http://2018.igem.org/Safety/Committee;
Lead Trainer/Teaching: Lead Trainer at National level for Laboratory Biosafety & Biosecurity in Pakistan conducted several
workshops in collaboration with FIC-NIH (US), BBIS (US) & PBSA (PK).
Publications: (Biosafety & Biosecurity) developed & co-authored a training module i.e. “Bioprism: A Laboratory safety
training initiative”, in collaboration with PBSA, FIC-NIH, mentored by Dr. Zeba Rasmussen, Sean Kaufman,
Dr Aamir Ikram, Dr Philippe Stroot etal. This work has been showcased at several National & Intl.
conferences, including 60th Annual ABSA conference, 2017 as well. Also this work has been copyrighted in
the form of a book (ISBN 978-969-23213-0-3, national library of Pakistan with publishing number 978-969)
Publications: (Molecular Epidemiology) 18 publications in total (02 in the lancet, 02 in Lancet ID, 03 in Lancet Global
Health, 01 in Clinical Infectious diseases, 02 in Plos one, 01 in Gastroenterology, 01 in Paediatrics, 01 in
AJTMH, 01 in JCM, 01 in BMC-ID, 01 in IJID & 02 in BBRJ). Few links are given below:
? http://www.sciencedirect.com/science/article/pii/S1473309914708084;
? http://www.sciencedirect.com/science/article/pii/S014067361631529X;
? http://www.sciencedirect.com/science/article/pii/S2214109X15001515;
? https://academic.oup.com/cid/article/62/10/1210/2462597/Norovirus-Infection-and-Acquired-Immunity-in-8;
? http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158199;
? http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0098796;
? http://www.bmbtrj.org/article.asp?issn=WKMP-0156;year=2017;volume=1;issue=1;spage=71;epage=75;aulast=Kabir;
? http://jcm.asm.org/content/early/2017/11/02/JCM.01374-17.full.pdf+html;
? http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2018;volume=2;issue=1;spage=63;epage=67;aulast=Kabir;
? https://www.sciencedirect.com/science/article/pii/S0140673618311279;
? https://www.sciencedirect.com/science/article/pii/S2214109X18303498;
Peer Reviewer: For Journal of Biotechnology and Biomedical Science Open Access Pub https://oap.manuscriptzone.net/;
Trained (In-Person): Aga Khan University (AKU, PK), Center of Disease control & prevention (CDC, USA), Intl. Vaccine Institute
(IVI, S. Korea), University of Virginia (UVA, USA), Univ. of Maryland (UMB, USA), Intl. Biocontainment
training Centre, Univ. of Texas Medical Branch (utmb, USA), National Institute of Health (NIH, USA), Sandia
National Laboratories & BEP, USA.

Primary Affiliation: Aga Khan University, Hospital - Karachi, Sindh , Pakistan

Specialties:

Additional Specialties:


View Mr. Furqan Kabir’s Resume / CV

Education

Sep 2018
SZABIST
MS/M.Phil.
Biosciences
Dec 2014
Institute of Business Management (IOBM/CBM)
MBA
Health
Dec 2004
University of Karachi
MSc
Biotechnology

Experience

Sep 2018
Manager, Outreach
Manager

Publications

18Publications

603Reads

3Profile Views

335PubMed Central Citations

Environmental Enteropathy in Undernourished Pakistani Children: Clinical and Histomorphometric Analyses.

Am J Trop Med Hyg 2018 Jun 29;98(6):1577-1584. Epub 2018 Mar 29.

Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4269/ajtmh.17-0306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086170PMC
June 2018
13 Reads
2.700 Impact Factor

A comparison of three diagnostic platforms for the detection of influenza A and B in children

Kabir F, Tariq M, Aziz F, Rizvi SI, Qureshi S, Ali A, Iqbal NT. A comparison of three diagnostic platforms for the detection of influenza A and B in children. Biomed Biotechnol Res J 2018;2:63-7

Biomed Biotechnol Res J [serial online]

Background: Viral flu is the predominant cause of hospitalization in young children, which invariably leads to enhanced morbidity and mortality in children in developing countries. Initial treatment of viral flu is based on presumptive diagnosis. Bedside testing is not common in clinical settings because of variable sensitivity and specificity of rapid tests in different settings. Methods: To address this issue, we evaluated the performance of Binax influenza A/B rapid testing kit against two robust molecular platforms (quantitative real-time polymerase chain reaction [qRT-PCR] and TaqMan array card [TAC]) in 24 nasopharyngeal (NP) swabs, collected from children under 5 years of age. Results: Binax was found to be less sensitive (56%), but 100% specific compared to qRT-PCR (100%) and TAC (>100%). Using TAC cards, 75% of samples were found to be coinfected with other bacterial and viral targets. Conclusion: Binax flu is suitable for bedside testing in clinical and community settings. The negative results of Binax should be interpreted with caution and confirmed by rapid molecular tests.

View Article
March 2018
106 Reads

Direct Detection of Shigella in Stool Specimens by Use of a Metagenomic Approach.

J Clin Microbiol 2018 02 24;56(2). Epub 2018 Jan 24.

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.01374-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786726PMC
February 2018
22 Reads
1 Citation
3.993 Impact Factor

Experience with the quantitative lytA gene real-time polymerase chain reaction for the detection of Streptococcus pneumoniae from pediatric whole blood in Pakistan

Kabir F, Muneer S, Kalam A, Sami A, Qureshi S, Hotwani A, Riaz A, Mohiuddin S, Yousafzai MT, Hussain S, Ali A, Shakoor S. Experience with the quantitative lytA gene real-time polymerase chain reaction for the detection of Streptococcus pneumoniae from pediatric whole blood in Pakistan. Biomed Biotec

Biomed Biotechnol Res J

Background: We present our experience with optimization and diagnostic use of quantitative real-time polymerase chain reaction (PCR) targeting the lytA gene of Streptococcus pneumoniae for the detection of S. pneumoniae in whole blood of children <5 years of age. The assay was optimized to detect ≥5 CFU/10 μl or 1 copy of DNA/2 μl of blood. Methods: This assay was applied on 1912 whole blood specimens collected from children <5 years of age with pneumonia, of which 35 specimens were lytA positive. The bacterial loads were determined through categorization of load into five different categories, i.e., very high load, high load, moderate load, low load, and very low load. Results: Of the 35 lytA-positive samples, 9 (25.71%), 4 (11.42%), 1 (2.85%), 13 (37.14%), and 8 (22.85%) were categorized as very high load, high load, moderate load, low load, and very low load, respectively. Extracted samples were also subjected to serotyping by the Centers for Disease Control and Prevention PCR scheme. Positive samples with very high load and high load category were serotyped successfully in all instances. A high proportion of samples with low and very low load (61.53% and 75%, respectively) remained untypeable by the currently proposed schemes. Conclusions: LytA PCR assay in whole blood provides rapid and sensitive results for the diagnosis of invasive S. pneumoniae disease in a resource-limited setting, while also being amenable to quantitation and serotyping.

View Article
July 2017
6 Reads

Pneumococcal serotypes and serogroups causing invasive disease in Pakistan, 2005-2013.

PLoS One 2014 3;9(6):e98796. Epub 2014 Jun 3.

Department of Pediatrics and Child Health, the Aga Khan University Hospital, Karachi, Pakistan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0098796PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043782PMC
January 2015
21 Reads
4 Citations
3.234 Impact Factor

Top co-authors

Shahida Qureshi
Shahida Qureshi

Aga Khan University

8
Ladaporn Bodhidatta
Ladaporn Bodhidatta

Armed Forces Research Institute of Medical Sciences

7
Eric R Houpt
Eric R Houpt

University of Virginia

7
Zulfiqar A Bhutta
Zulfiqar A Bhutta

The Hospital for Sick Children

6
Gagandeep Kang
Gagandeep Kang

Christian Medical College

6
Jie Liu
Jie Liu

University of Virginia

6
Rashidul Haque
Rashidul Haque

University of Virginia

6
Jean Gratz
Jean Gratz

University of Virginia

6
Adil Kalam
Adil Kalam

The Aga Khan University

6